Jazz Pharmaceuticals Picks Up SpringWorks Assets For $35M

Jazz Pharmaceuticals plc is set to buy assets from SpringWorks Therapeutics Inc. for an upfront payment of $35 million.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.